Background Renal transplant is the treatment of choice for patients with end-stage renal disease. To prevent graft rejection, recipients are receiving a combination of immunosuppressive medications. Among common side effects of the therapy, many oral manifestations are found either as a direct effect of the drugs or due to suppression of the immune system. Objectives This study aimed to investigate oral problems and their relation to the oral hygiene status of the recipients. Patients and methods This cross-sectional study was performed on 150 renal transplant recipients in Sulaimani city, Kurdistan Region, Iraq, from December 2018 to June 2019. Any existing condition was diagnosed on a clinical basis. Additional data including a questionnaire of demographic, pharmacologic, and transplant duration were also collected. Results The 150 transplant recipients included 103 males and 47 females (mean age 40.5 years). A total of 22.1% had at least one oral lesion. The most common lesion was gingival hyperplasia in 16.7% of cases who received cyclosporine A as the primary immunosuppressive medication, followed by candida infection 4.7%, which were mostly in patients with a transplant duration of less than 3 months. Conclusion In this study, we reported a lower incidence of oral lesions compared to other studies published in the literature. Improvement of oral hygiene status of the recipients is associated with reduced oral manifestation specifically gingival hyperplasia. Also, using prophylactic antifungal and antiviral agents during the first few months of transplant has a direct effect on reducing the number and frequency of viral and fungal infections.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.